Highlights and Quick Summary
- Capex to Sales for the quarter ending June 30, 2023 was 0.0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Capex to Sales decreased by NaN%
- Annual Capex to Sales for 2022 was 0.0 (a NaN% decrease from previous year)
- Annual Capex to Sales for 2021 was 0.0 (a NaN% decrease from previous year)
- Annual Capex to Sales for 2020 was 0.0 (a NaN% decrease from previous year)
- Twelve month Capex to Sales ending June 30, 2023 was 0.0 (a NaN% decrease compared to previous quarter)
- Twelve month trailing Capex to Sales decreased by NaN% year-over-year
Trailing Capex to Sales for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| 0.0 | 0.0 | 0.0 | 0.0 |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex to Sales of Dyne Therapeutics, Inc.
Most recent Capex to Salesof DYN including historical data for past 10 years.Interactive Chart of Capex to Sales of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Capex to Sales for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.0 | 0.0 | – | – | – |
| 2022 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 2021 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 2020 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 2019 | 0.0 | 0.0 | – | – | 0.0 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology